Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CELZ
#5903
Creative Medical Technology Holdings, Inc. Common Stock
1.8
1
-0.55%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.55%
Monthly Change
-15.02%
6 month change
-43.79%
Cambio anual
-64.51%
Cierres anteriores
1.8
2
Open
1.8
1
Bid
Ask
Low
1.8
1
High
1.8
1
Volumen
1
Markets
Acciones
Atención Sanitaria
CELZ
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
227.29 K
651.47 K
1.41 M
1.36 M
1.75 M
—
Valuation ratios
Enterprise value
—
—
—
2.77 M
4.04 M
25.08 M
Price to earnings ratio
—
—
—
—
-0.62
—
Price to sales ratio
—
—
—
—
310.89
—
Price to cash flow ratio
—
—
—
—
-0.65
—
Price to book ratio
—
—
—
—
0.54
—
Enterprise value to EBITDA ratio
—
—
—
-0.49
-0.7
-4.16
Profitability ratios
Return on assets %
50.61
1.7
-0.53
-0.49
-0.82
-0.86
Return on equity %
0.91
1.88
-0.64
-0.51
-0.87
-0.9
Return on invested capital %
18.12
-60.37
-6 565.73
-612.2
—
—
Gross margin %
69.24
45.36
67.84
60
60
—
Operating margin %
677.71
-3 562.17
-11.56 K
-62.45 K
-52.22 K
—
EBITDA margin %
-677.71
-3 562.17
-11.56 K
-62.45 K
-52.22 K
—
Net margin %
22.08 K
21.89 K
-11.45 K
-58.74 K
-49.94 K
—
Liquidity ratios
Quick ratio
—
10.21
5.64
27.64
18.72
90.69
Current ratio
0
10.22
5.64
27.65
18.73
90.71
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.26
0.01
0.01
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
1.82
0
—
—
—
—
Long term debt to total equity ratio
0.03
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
-6.82
-7.13
—
-3.58
-3.02
EBIT per share
—
-9.62
-9.37
—
-3.88
-3.1
EBITDA per share
—
-9.62
-9.37
—
-3.88
-3.1
Total debt per share
—
—
—
—
—
—
Cash per share
—
33.01
16.83
—
—
—
Net current asset value per share
—
33.05
17.15
—
4.14
12.77
Tangible book value per share
—
29.83
14.09
—
3.93
12.19
Working capital per share
—
29.82
14.11
—
3.92
12.2
Book value per share
—
31.45
14.51
—
4.28
13.17
Noticias
Creative Medical recibe designación de la OMS para segunda terapia celular
Creative Medical receives WHO designation for second cell therapy
Creative Medical reporta datos positivos para terapia de dolor de espalda
Creative Medical reports positive interim data for back pain therapy
La iniciativa BioDefense de Creative Medical recibe aprobación regulatoria
Creative Medical’s BioDefense initiative receives regulatory approval
Accionistas de Creative Medical Technology aprueban propuesta de ejercicio de warrants
Los accionistas de Creative Medical Technology aprueban propuesta de ejercicio de warrants
Creative Medical Technology stockholders approve warrant exercise proposal
Creative Medical completa la inscripción en ensayo de dolor crónico de espalda
Creative Medical completes enrollment in chronic back pain trial
La OMS aprueba olastrocel como nombre internacional para la terapia CELZ-201